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INTRODUCTION: Direct chemical control of transcription factors at their sites of action, i.e. at 
the protein-DNA level, is currently unavailable for most transcription factors, including the ETS-
family transcription factor PU.1, an essential regulator of hematopoiesis. A major challenge in 
developing direct activators of PU.1 is the strong structural homology it shares with the ETS-
family protein Ets-1 (and the ETS family in general). This project aims to overcome the 
challenge of achieving specificity in targeting PU.1 over its structural homologs. Recent studies 
by the Poon Lab on the mechanisms of DNA site recognition by PU.1 and Ets-1 show striking 
differences in molecular hydration accompanying DNA recognition, an exploitable feature that 
we use in this study to identify and characterize new compounds that directly activate the 
transcription factor PU.1.  
 
METHOD: Compounds that bind to the PU.1/DNA complex and retain PU.1’s osmotic sensitivity 
are candidates for acting as direct activators of PU.1. We employ osmotically-directed phage 
display screening of 7- and 12-residue peptide libraries against the PU.1/DNA complex in our 
search for these compounds. Successful enrichment is expected to yield 5 to 10 optimized 
sequence candidates. The thermodynamic, kinetic, and structural basis of PU.1 activation by 
these candidate peptides will be determined using biophysical and biochemical methods 
including surface plasmon resonance, hydrolytic probes, and mass spectrometric analyses. 
RESULTS: Preliminary experiments to validate the phage display system were conducted 
initially. After validation of the experimental design, panning was carried out against a DNA-only 
target using magnetic streptavidin beads. Eight clones were identified as potential candidates 
for peptide binders of the high affinity in vivo “consensus” DNA sequence for PU.1.  
CONCLUSION: Fluorescence anisotropy studies for characterization of the binding properties 
of the potential candidates are currently underway. In addition, N-hydroxysuccinimide (NHS) 
coupling is being explored as an option for solid-surface binding assays that preserve the 
dynamic nature of PU.1/DNA interactions with phage in solution. Panning using the NHS 
method of target immobilization will be done against the PU.1/DNA complex as a target. 
